Scientific article

Urologie : ce qui a changé en 2022

Other titleUrology: what's new in 2022
Published inRevue médicale suisse, vol. 19, no. 809-10, p. 86-89
Publication date2023-01-18

Over the last year, urologic progress remains driven by evolutions in oncological and functionnal urology. Prostate cancer imaging modalities are improving, as well as treatment options for advanced stages. Kidney and bladder cancer are benefiting from new treatment modalities including immunotherapy, whose role in the peri-operative setting is still unclear. Surveillance startegies for testicular cancer has been greatly simplified, for the benefit of the patients. In functional urology, a new therapeutic class in now available for the treatment of overactive bladder. Mutliples alternatives to transurethral resection are emerging in the surgical treatment of benign prostatic hypertrophy, whose expected benefits will need to be validated by long-term studies.

  • Humans
  • Male
  • Prostatic Hyperplasia / diagnosis
  • Prostatic Hyperplasia / surgery
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / surgery
  • Testicular Neoplasms
  • Urologic Surgical Procedures
  • Urology
Citation (ISO format)
PEIXOTO OLIVEIRA, Nelson et al. Urologie : ce qui a changé en 2022. In: Revue médicale suisse, 2023, vol. 19, n° 809-10, p. 86–89. doi: 10.53738/REVMED.2023.19.809-10.86
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 07/19/2024
ISSN of the journal1660-9379

Technical informations

Creation01/23/2023 10:02:00 AM
First validation01/23/2023 10:02:00 AM
Update time03/16/2023 10:38:50 AM
Status update03/16/2023 10:38:49 AM
Last indexation01/17/2024 11:03:19 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack